In this whitepaper we look at how understanding the biodistribution profile of a gene therapy product following in vivo administration is essential for the prediction and assessment of therapy’s efficacy and toxicity profiles in non-clinical and clinical studies.
To learn more, please complete the form below to download this whitepaper: Biodistribution & Shedding for CGT
